Cost-benefit of outcome adjudication in nine randomised stroke trials.
Peter J GodolphinPhilip M BathAle AlgraEivind BergeJohn ChalmersMisha EliasziwGraeme J HankeyNaohisa HosomiAnnamarei RantaChristian WeimarLisa J WoodhouseAlan A MontgomeryPublished in: Clinical trials (London, England) (2020)
Central adjudication is a time-consuming and potentially costly process. These costs need to be considered when designing a trial and should be evaluated alongside the potential benefits adjudication brings to determine whether they outweigh this expense.